Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Dr. Shirley Fox, an obstetric hospitalist with nearly 30 years at Oregon’s largest Providence hospital, never imagined herself on a picket line. After all, vanishingly few physicians have ...

The suit stems from the diss track “Not Like Us” by Kendrick Lamar, another UMG artist. Drake’s legal complaint also again accuses UMG of using bots on Spotify and other streaming platforms ...

No difference in thyroid cancer risk was found for adults with type 2 diabetes using a GLP-1 receptor agonist vs. those using a DPP-IV inhibitor. Women may have a lower risk for thyroid cancer ...

Glucagon-like peptide-1 (GLP-1) is a fullness hormone that helps the body regulate blood sugar, appetite and metabolism. Ozempic, Mounjaro, Wegovy and similar drugs are GLP-1 receptor agonists ...